See All Slides - tctmd.com

Slides

Presentation TCT 2022

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

Presenter: Shinichiro Masuda

September 19, 2022

Presentation TCT 2022

TCT 254: Histology-Trained Deep Learning Methodology for Automated Coronary Plaque Component Classification in Combined Intravascular Ultrasound-Optical Coherence Tomography Images

Presenter: Retesh Bajaj

September 19, 2022

Presentation TCT 2022

Keynote Lecture: Complications Following TAVR ViV: Prevention and Management

Presenter: Haim Danenberg

September 19, 2022

Presentation TCT 2022

Keynote Lecture: Essentials of Hemodynamic Support in CHIP

Presenter: John Lasala

September 19, 2022

Presentation TCT 2022

The CLASP II Trial: First 30-Day Procedural and Clinical Outcomes Report From the Roll-in Cohort

Presenter: Charles J. Davidson

September 19, 2022

Presentation TCT 2022

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Intro

Presenter: Sanjum Sethi

September 19, 2022

Presentation TCT 2022

TEER Planning: Real-World Situations Where Multi-Modality Imaging Is Recommended (Case-Based)

Presenter: Joao L. Cavalcante

September 19, 2022

Presentation TCT 2022

TCT 303: Continuous versus bolus thermodilution derived CFR and MRR and their association with symptoms of CMD: a head-to-head comparison

Presenter: Tijn Jansen

September 19, 2022

Presentation TCT 2022

TCT 252: Comparison of the estimations of ElucidVivo software and NIRS-IVUS for lumen, vessel wall and plaque dimensions and it’s composition

Presenter: Ramya Parasa

September 19, 2022

Presentation TCT 2022

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

Presenter: Teresa Carman

September 19, 2022

Advertisement

Slides

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

TCT 254: Histology-Trained Deep Learning Methodology for Automated Coronary Plaque Component Classification in Combined Intravascular Ultrasound-Optical Coherence Tomography Images

Keynote Lecture: Complications Following TAVR ViV: Prevention and Management

Keynote Lecture: Essentials of Hemodynamic Support in CHIP

The CLASP II Trial: First 30-Day Procedural and Clinical Outcomes Report From the Roll-in Cohort

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Intro

TEER Planning: Real-World Situations Where Multi-Modality Imaging Is Recommended (Case-Based)

TCT 303: Continuous versus bolus thermodilution derived CFR and MRR and their association with symptoms of CMD: a head-to-head comparison

TCT 252: Comparison of the estimations of ElucidVivo software and NIRS-IVUS for lumen, vessel wall and plaque dimensions and it’s composition

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content